Home » Topics » Regulatory

Regulatory
RSS

Schering-Plough claims novel use for Flt3 ligand

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

Spray formulation of antimigraine Rx cleared for marketing

Dec. 20, 1996

Advisory committee recommends approval of non-nicotine smoking cessation product

Dec. 13, 1996

First marketing approval for Allergan antipsoriatic

Dec. 13, 1996

5-LO inhibitor approved by FDA

Dec. 13, 1996

First approval for Pharmacyclics' MRI contrast agent

Dec. 12, 1996

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

Dec. 12, 1996

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.